Achieving cost savings in NIPT by enabling greater flexibility in blood collection tube choice

The development of prenatal molecular testing has progressed from the early large segment chromosomal abnormality observation method, to DNA microarray technology, then into whole genome sequencing (WGS) and whole exome sequencing (WES), with every stage having its own advantages and disadvantages.